Skadden advised Eyebiotech Limited, while Gibson, Dunn & Crutcher advised Merck the deal. Merck, known as MSD outside of the United States and Canada, and Eyebiotech...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher advised March Capital on the transaction. Luminance, the leader in ‘legal-grade’ AI, announced that it raised $40 million in a Series B funding...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher LLP advised LyondellBasell on the offering. LyondellBasell (NYSE: LYB) announced that LYB International Finance III, LLC, its wholly-owned subsidiary, priced a public offering of $750,000,000...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher LLP advised Brown-Forman Corporation in the deal. Brown-Forman Corporation (NYSE:BFA, BFB) announced that it has reached an agreement to sell its Finlandia...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher LLP advised Sumeru Equity Partners on its investment in Zappi. Zappi, the leading consumer insights platform designed for creators, announced it has...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher and Loyens & Loeff have advised Mondelez International Holdings Netherlands B.V., while White & Case LLP has advised the Sole Global Coordinator...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis and Elvinger Hoss Prussen advised Vitruvian Partners on the deal. Gibson, Dunn & Crutcher LLP advised European-Asian private equity firm AGIC Capital. London-based...
You must be a Standard 1 Year member to access this content.
Baker McKenzie, working alongside Honigman LLP, advised Wolverine Worldwide on the acquisition of Sweaty Betty, assisted by Pinsent Masons. Gibson, Dunn & Crutcher LLP acted for...
You must be a Standard 1 Year member to access this content.
